Dr. Molly Detgen Magnano, MD

Dr. Magnano practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Magnano's NPI, 1992743579, was assigned on June 3, 2006. Dr. Magnano graduated from Loyola University Chicago Stritch School of Medicine in 2001. Dr. Magnano holds California license A80346.

Dr. Magnano's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Magnano's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Magnano is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Magnano to 4 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magnano practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Magnano's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Magnano is board certified in rheumatology by the American Board of Internal Medicine. Dr. Magnano is licensed in California.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint arthropathy, joint cyst, joint pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Magnano treats.

CMS data shows 15,598 Medicare services from Dr. Magnano across 13 procedure codes in 2024, for 304 Medicare patients. Medicare paid $252,989 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Magnano in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have arthritis, and 72% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Magnano's median patient age at 67, with 75% women.

In 2024, Dr. Magnano wrote 1,888 Medicare Part D claims for 308 patients. 76% of them were for generic drugs. CMS names the drug for 1,656 of them, across 38 drugs with 11 or more claims each, at $2,157,237 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Magnano for performance year 2024, reported as part of a group. Dr. Magnano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Magnano as offering telehealth.

Dmand AI links 4 papers to Dr. Magnano in 2007. The most frequent topics are Antibodies, Monoclonal, Antirheumatic Agents and Arthritis, Rheumatoid. Dr. Magnano's most frequent co-authors are Mark Christopher Genovese, MD, Corrie D. Broudy, MD and Thomas Martin Bush, MD.

CMS Open Payments shows 297 general payments to Dr. Magnano from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,581.

Dmand AI lists 4 awards for Dr. Magnano, most recently Regional Top Doctor in 2021.

Dr. Magnano graduated from Loyola University Chicago Stritch School of Medicine in 2001. Dr. Magnano is a member of ACR.

Dr. Magnano is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.